Clinical Trial

Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms

Name: Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms — clinical trial record (NCT07549451)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To learn if imetelstat can help to control MDS/MPNs.

Trial Details

NCT Number	NCT07549451
Lead Sponsor	M.D. Anderson Cancer Center Collaborators: Geron Corporation
Conditions	Phase II, Imetelstat, Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases
Enrollment	30 participants
Start Date	2026-10-08
Primary Completion	2027-05-31 (estimated)
Study Completion	2027-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-24